Botulism, Clinical Infectious Diseases, vol.178, issue.1, pp.1167-1173, 2005. ,
DOI : 10.1086/515615
Uptake of Botulinum Neurotoxin in the Intestine, Curr Top Microbiol Immunol, vol.364, pp.45-59, 2013. ,
DOI : 10.1007/978-3-662-45790-0_3
A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins, The Journal of Infectious Diseases, vol.285, issue.2, pp.183-191, 2014. ,
DOI : 10.1001/jama.285.8.1059
Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene, The Journal of Infectious Diseases, vol.235, issue.2, pp.192-202, 2014. ,
DOI : 10.1111/j.1574-6968.2004.tb09561.x
A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin, Journal of Infectious Diseases, vol.32, issue.3, pp.379-385, 2016. ,
DOI : 10.1093/infdis/150.3.407
Botulinum toxins: Mechanisms of action, antinociception and clinical applications, Toxicology, vol.306, pp.124-146, 2013. ,
DOI : 10.1016/j.tox.2013.02.006
A Massive Outbreak of Type E Botulism Associated with Traditional Salted Fish in Cairo, Journal of Infectious Diseases, vol.167, issue.2, pp.451-454, 1993. ,
DOI : 10.1093/infdis/167.2.451
Experience with the Use of an Investigational F(ab')2 Heptavalent Botulism Immune Globulin of Equine Origin During an Outbreak of Type E Botulism in Egypt, Clinical Infectious Diseases, vol.23, issue.2, pp.337-340, 1996. ,
DOI : 10.1093/clinids/23.2.337
Two cases of food-borne botulism in Finland caused by conserved olives, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011. ,
Two outbreaks of botulism associated with consumption of green olive paste, France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011. ,
Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains, BMC Microbiology, vol.14, issue.1, p.25031122, 2014. ,
DOI : 10.1186/1471-2180-14-192
Adult botulism type F in the United States, 1981-2002, Neurology, vol.65, issue.11, pp.1694-1700, 1981. ,
DOI : 10.1212/01.wnl.0000187127.92446.4c
Neurotoxins Affecting Neuroexocytosis, Physiological Reviews, vol.267, issue.2, pp.717-766, 2000. ,
DOI : 10.1007/BF00498693
Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-1070, 2001. ,
DOI : 10.1001/jama.285.8.1059
Antibodies for biodefense, mAbs, vol.2, issue.6, pp.517-527, 2011. ,
DOI : 10.4161/mabs.2.3.11416
URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.3.6.17621?needAccess=true
Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future, Montrerey Inst Int Stud.Occasional Paper, issue.1, 1999. ,
How Japan Germ Terror Alerted World. The New York Times Available: http://www.nytimes.com/1998/05/26/world/sowing-death-a-special- report-how-japan-germ-terror-alerted-world.html, A special report, 1998. ,
Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk, Proceedings of the National Academy of Sciences, vol.334, issue.20, pp.9984-9989, 2005. ,
DOI : 10.1056/NEJM199605163342001
Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-570, 1980. ,
DOI : 10.1016/0002-9343(80)90469-6
Infant Botulism and Treatment With BIG-IV (BabyBIG??), The Pediatric Infectious Disease Journal, vol.26, issue.3, pp.261-262, 2007. ,
DOI : 10.1097/01.inf.0000256442.06231.17
Human Botulism Immune Globulin for the Treatment of Infant Botulism, New England Journal of Medicine, vol.354, issue.5, pp.462-471, 2006. ,
DOI : 10.1056/NEJMoa051926
Development of humanlike scFv-Fc antibodies neutralizing Botulinum toxin serotype B. mAbs, pp.1161-1177, 2015. ,
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library, mAbs, vol.57, issue.2, pp.446-459, 2014. ,
DOI : 10.1038/2338
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain, BMC Biotechnology, vol.53, issue.2, pp.86-26382731, 2015. ,
DOI : 10.1016/j.toxicon.2009.01.019
Antibody Humanization Methods for Development of Therapeutic Applications, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.33, issue.2, pp.67-73, 2014. ,
DOI : 10.1089/mab.2013.0080
Non-human primate immune libraries combined with germline humanization, mAbs, vol.146, issue.4, pp.377-381, 2009. ,
DOI : 10.1016/j.critrevonc.2007.04.011
"Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 1950. ,
DOI : 10.4049/jimmunol.169.2.1119
The Contribution of Somatic Hypermutation to the Diversity of Serum Immunoglobulin, Immunity, vol.13, issue.3, pp.409-417, 2000. ,
DOI : 10.1016/S1074-7613(00)00040-6
Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering, Journal of Molecular Biology, vol.384, issue.5, pp.1400-1407, 2008. ,
DOI : 10.1016/j.jmb.2008.10.033
URL : https://hal.archives-ouvertes.fr/hal-00345933
Germline humanization of a murine A?? antibody and crystal structure of the humanized recombinant Fab fragment, Protein Science, vol.2, issue.2, pp.299-308, 2010. ,
DOI : 10.1212/01.WNL.0000073623.84147.A8
IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties, Journal of Molecular Recognition, vol.17, issue.1, pp.17-32, 2004. ,
DOI : 10.1002/jmr.647
WAM: an improved algorithm for modelling antibodies on the WEB, Protein Engineering, Design and Selection, vol.13, issue.12, pp.819-824, 2000. ,
DOI : 10.1084/jem.132.2.211
Allergic asthma and an anti-CD23 mAb (IDEC-152) Results of a phase I, single-dose, dose-escalating clinical trial, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.563-570, 2003. ,
DOI : 10.1016/S0091-6749(03)01861-X
Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia, Clinical Cancer Research, vol.13, issue.15, pp.4448-4455, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-1463
A human scFv antibody generation pipeline for proteome research, Journal of Biotechnology, vol.152, issue.4, p.20883731, 2011. ,
DOI : 10.1016/j.jbiotec.2010.09.945
"Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 1950. ,
DOI : 10.4049/jimmunol.169.2.1119
Botulinum type A toxin neutralisation by specific IgG and its fragments: A comparison of mouse systemic toxicity and local flaccid paralysis assays, Toxicon, vol.48, issue.3, pp.246-254, 2006. ,
DOI : 10.1016/j.toxicon.2006.05.007
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proceedings of the National Academy of Sciences, vol.287, issue.5458, pp.11346-11350, 2002. ,
DOI : 10.1126/science.287.5458.1664
Antibody Protection against Botulinum Neurotoxin Intoxication in Mice, Infection and Immunity, vol.77, issue.10, pp.4305-4313, 2009. ,
DOI : 10.1128/IAI.00405-09
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.18714390, 2008. ,
DOI : 10.1371/journal.pone.0003023.t002
Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity, PLoS ONE, vol.13, issue.8, p.20865035, 2010. ,
DOI : 10.1371/journal.pone.0012416.s003
Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A, PLoS ONE, vol.328, issue.333, p.20967241, 2010. ,
DOI : 10.1371/journal.pone.0013245.t004
URL : https://hal.archives-ouvertes.fr/pasteur-01762123
Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E, PLOS ONE, vol.384, issue.10, p.26440796, 2015. ,
DOI : 10.1371/journal.pone.0139905.s001
URL : https://hal.archives-ouvertes.fr/pasteur-01325687
UCSF Chimera?A visualization system for exploratory research and analysis, Journal of Computational Chemistry, vol.373, issue.13, pp.1605-1612, 2004. ,
DOI : 10.1002/jcc.20084
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells, BMC Biotechnol, vol.13, p.23802841, 2013. ,
Molecular aspects of human Fc??R interactions with IgG: Functional and therapeutic consequences, Immunology Letters, vol.106, issue.2, pp.111-118, 2006. ,
DOI : 10.1016/j.imlet.2006.05.009
Limulus amoebocyte lysate assay for detection and quantitation of endotoxin in a small-volume parenteral product, Appl Environ Microbiol, vol.40, pp.533-538, 1980. ,
On the separation mechanism of capillary sodium dodecyl sulfate-gel electrophoresis of proteins, Electrophoresis, vol.7, issue.1, pp.611-616, 1995. ,
DOI : 10.1016/S0026-0495(64)80018-4
-Glycans by Capillary Electrophoresis, Analytical Chemistry, vol.83, issue.13, pp.5329-5336, 2011. ,
DOI : 10.1021/ac2007587
Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A, Journal of Molecular Biology, vol.351, issue.1, pp.158-169, 2005. ,
DOI : 10.1016/j.jmb.2005.06.003
Kinetic analysis of biosensor data: elementary tests for self-consistency, Trends in Biochemical Sciences, vol.21, issue.12, pp.458-460, 1996. ,
DOI : 10.1016/S0968-0004(96)20025-8
Detection of antibodies against botulinum toxins, Movement Disorders, vol.101, issue.S8, pp.85-91, 2004. ,
DOI : 10.1016/S0041-0101(01)00288-4
Characterization of botulinum neurotoxin type A subtypes by immunocapture enrichment and liquid chromatography???tandem mass spectrometry, Analytical and Bioanalytical Chemistry, vol.330, issue.1???2 ,
DOI : 10.1016/j.jim.2007.11.006